Expression and functional role of β3-adrenoceptors in the human ureter

International Journal of Urology

Volumn 20, Issue 10, 2013, Pages 1007-1014

  Matsumoto, Rikiya ^a   Otsuka, Atsushi ^a   Suzuki, Takahisa ^a   Shinbo, Hitoshi ^b   Mizuno, Takuji ^c   Kurita, Yutaka ^b   Mugiya, Soichi ^a   Ozono, Seiichiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Enshu Hospital   (Japan)

^c Iwata City Hospital   (Japan)

Author keywords

3 adrenoceptor agonist; Human ureter; Immunohistochemistry; Reverse transcription polymerase chain reaction; TRK 380

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; PROCATEROL; RNA; SALBUTAMOL; TRK 380; UNCLASSIFIED DRUG;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROSTIMULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URETER;

HUMAN URETER; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRK-380; Β3-ADRENOCEPTOR AGONIST;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADRENERGIC BETA-AGONISTS; AGED; AGED, 80 AND OVER; ALBUTEROL; ETHANOLAMINES; FEMALE; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PROCATEROL; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPATHETIC NERVOUS SYSTEM; URETER; UROTHELIUM;

EID: 84884989983     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12093     Document Type: Article

References (34)

1. Deane RF. Functional studies of the ureter: its behaviour in the domestic pig (Sus scrofa domestica) as recorded by the technique of Trendelenburg. Br. J. Urol. 1967; 39: 31-37.
2. Schulman CC. Electron microscopy of the human ureteric innervation. Br. J. Urol. 1974; 46: 609-623.
3. Schulman CC. Ultrastructural evidence for adrenergic and cholinergic innervation of the human ureter. J. Urol. 1975; 113: 765-771.
4. Weiss RM. Physiology and pharmacology of the renal pelvis and ureter. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds). Campbell's Urology, 10th edn. W.B. Saunders, Philadelphia, PA, 2011; 1755-1785.
5. 1-Adrenoceptors in the urinary tract. Handb. Exp. Pharmacol. 2011; 202: 283-306.
6. Michel MC. β-Adrenergic receptor subtypes in the urinary tract. Handb. Exp. Pharmacol. 2011; 202: 307-318.
7. Hollingsworth JM, Rogers MA, Kaufman SR etal. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006; 368: 1171-1179.
8. Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann. Emerg. Med. 2007; 50: 552-563.
9. Beach MA, Mauro LS. Pharmacologic expulsive treatment of ureteral calculi. Ann. Pharmacother. 2006; 40: 1361-1368.
10. Lipkin M, Shah O. Medical therapy of stone disease: from prevention to promotion of passage options. Curr. Urol. Rep. 2009; 10: 29-34.
11. Seitz C, Liatsikos E, Porpiglia F etal. Medical therapy to facilitate the passage of stones: what is the evidence? Eur. Urol. 2009; 56: 455-471.
12. Tomiyama Y, Hayakawa K, Shinagawa K etal. β-Adrenoceptor subtypes in the ureteral smooth muscle of rats, rabbits and dogs. Eur. J. Pharmacol. 1998; 352: 269-278.
13. Tomiyama Y, Murakami M, Yamazaki Y etal. Comparison between CL-316243- and CGP-12177A-induced relaxations in isolated canine ureter. Pharmacology 2003; 68: 140-146.
14. Wanajo I, Tomiyama Y, Yamazaki Y etal. Pharmacological characterization of β-adrenoceptor subtypes mediating relaxation in porcine isolated ureteral smooth muscle. J. Urol. 2004; 172: 1155-1159.
15. Park YC, Tomiyama Y, Hayakawa K etal. Existence of a β3-adrenoceptor and its functional role in the human ureter. J. Urol. 2000; 164: 1364-1370.
16. 3-adrenoceptor agonist, on bladder function. J. Pharmacol. Exp. Ther. 2007; 321: 642-647.
17. 3-adrenoceptor agonist, on mammalian detrusor strips. Urology 2012; 79: 744.e1-7447.
18. 3-adrenoceptor agonist, AJ-9677, on relaxation of the detrusor muscle: an in vitro study. Int. J. Urol. 2008; 15: 1072-1076.
19. Otsuka A, Shinbo H, Matsumoto R etal. Expression and functional role of β-adrenoceptors in the human urinary bladder urothelium. Naunyn. Schmiedebergs Arch. Pharmacol. 2008; 377: 473-481.
20. Michel MC, Wieland T, Tsujimoto G. How reliable are G-protein-coupled receptor antibodies? Naunyn. Schmiedebergs Arch. Pharmacol. 2009; 379: 385-388.
21. Pradidarcheep W, Stallen J, Labruyère WT, Dabhoiwala NF, Michel MC, Lamers WH. Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors. Naunyn. Schmiedebergs Arch. Pharmacol. 2009; 379: 397-402.
22. Hamdani N, van der Velden J. Lack of specificity of antibodies directed against human beta-adrenergic receptors. Naunyn. Schmiedebergs Arch. Pharmacol. 2009; 379: 403-407.
23. Limberg BJ, Andersson KE, Kullmann AF etal. β-Adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder. Cell Tissue Res. 2010; 342: 295-306.
24. Otsuka A, Kawasaki H, Matsumoto R etal. Expression of β-adrenoceptor subtypes in urothelium, interstitial cells and detrusor of the human urinary bladder. LUTS 2013; doi: 10.1111/luts.12007
25. Hong SK, Kwak C, Chang Jeong B etal. Involvement of Rho-kinase in the contractile mechanism of human ureteral smooth muscle. Neurourol. Urodyn. 2005; 24: 136-141.
26. 3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome. Neurourol. Urodyn. 2010; 29: 1320-1325.
27. Kullmann FA, Downs TR, Artim DE etal. Urothelial beta-3 adrenergic receptors in the rat bladder. Neurourol. Urodyn. 2011; 30: 144-150.
28. Tomiyama Y, Murakami M, Akiyama K etal. Modification of ureteral motility and promotion of urine flow around an intraureteral obstruction by CL-316243, phenylephrine, and furosemide in dogs. Neurourol. Urodyn. 2002; 21: 251-257.
29. Wanajo I, Tomiyama Y, Yamazaki Y etal. Ureteral selectivity of intravenous beta-adrenoceptor agonists in pig model of acute ureteral obstruction: comparison of KUL-7211, a selective beta2/beta3 agonist, with isoproterenol, terbutaline, and CL-316243. Urology 2011; 77: 1266.e1-6.
30. 2-adrenoceptor agonist, procaterol and salbutamol in asthma. Br. J. Clin. Pharmac. 1985; 19: 787-791.
31. 2-agonist in bronchial asthma. J. Allergy Clin. Immunol. 1985; 75: 698-705.
32. 3-adrenoceptor agonist, in patients with overactive bladder (OAB). Eur. Urol. Suppl. 2010; 9: 249.
33. Nitti V, Herschorn S, Auerbach S etal. The efficacy and safety of mirabegron in patients with overactive bladder syndrome - results from a North-American Phase III trial. Eur. Urol. Suppl. 2011; 10: 278.
34. Khullar V, Cambronero J, Stroberg P etal. The efficacy and tolerability of mirabegron in patients with overactive bladder - results from a European-Australian Phase III trial. Eur. Urol. Suppl. 2011; 10: 278.